Fact Check: Is ivermectin a good treatment for COVID-19

Research is proceeding on optimal doses for efficacy and likely safety, the WHO is directing additional focus to Ivermectin, and the Bill and Melinda Gates Foundation is supporting redirection of US $19 million of its grant funds to repurposing Ivermectin for COVID management (2). Trials with Ivermectin are not yet listed among the COVID-19 clinical trials dashboard (3). Trials could be implemented immediately of oral Invermectin at current therapeutic doses (often two single doses a week apart), which are generally safe, to assess its efficacy in both treatment and prophylaxis of COVID infections.

Measurements and main results: The primary outcome was respiratory and cardiovascular organ support-free days, assessed on an ordinal scale combining in-hospital death (assigned a value of -1) and days free of organ support through day 21 in ...

And scientists initially hoped it might treat COVID-19, too, prompting many people to embrace it, though dozens of studies later confirmed the drug is not an effective treatment. Despite the disappointing research results, ivermectin took off ...

Most studies since have found no benefit. ... 2021 study from Colombia found that taking ivermectin for 5 days did not significantly improve symptom duration in people with mild COVID-19 compared with a placebo.

Claims that ivermectin, hydroxychloroquine or chloroquine can treat COVID-19 are false. These medicines are still useful for treating other illnesses. But only medicines approved or authorized by the U.S.

A prominent analysis of ivermectin by the highly reputable Cochrane Library, Popp et al. (2026), claims that the consensus of the academic literature is that ivermectin was ineffective against COVID.

There was no significant difference in the proportion of participants who converted to a positive RAT or PCR between the Ivermectin and placebo arms, even after controlling for age and history of previous infection with SARS-CoV-2 (absolute ...

In July 2021 Andrew Hill, a senior research fellow at Liverpool University, published a meta-analysis of ivermectin use for COVID which suggested it may be beneficial. However, as research fraud subsequently emerged in some studies included in the meta-analysis, Hill revised his analysis to ...

The authors noted that the completed studies were small and “few are considered high quality.” They concluded that “reliable evidence does not support the use of ivermectin for treatment or prevention of COVID-19” except within well-designed ...